Corrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China - Jia Liu; Jia Liu; Lidan Cao; Lidan Cao; Jing Wu; Jing Wu (Frontiers Media S.A., 2022)